L-NAME is an
in vivo and in vitro inhibitor of NO synthase (NOS) [19,20] and in
the present study, we have also observed a clear decrease in the
aorta relaxing effects of CFP when the rings were incubated with
L-NAME. A clear increase in SBP was observed in the L-NAME treated SHR.